Draft:Compact Sequencing

Submission rejected on 2 August 2026 by Guninvalid (talk). The subject is contrary to the purpose of Wikipedia. Rejected by Guninvalid 17 days ago. Last edited by Guninvalid 17 days ago. Ask for advice

Submission declined on 30 March 2026 by WeirdNAnnoyed (talk). This draft appears to contain text generated by a large language model (such as ChatGPT). You cannot use LLMs to generate article content. LLM-generated pages with certain obvious signs of being machine generated may be deleted without notice. Instead, only summarize in your own words a range of independent, reliable, published sources that discuss the subject. See the advice page on large language models for more information. This draft reads like an advertisement. Wikipedia is an encyclopedia, not a platform for promotion or marketing. Drafts that are exclusively promotional may be deleted without notice. Wikipedia articles must be written neutrally in a formal, impersonal, and dispassionate way. They should not read like a blog post, advertisement, or fan page. Rewrite the draft to remove: promotional language: see Words to watch; personal commentary: opinions or direct addresses to the reader; informal language. Instead, only summarize in your own words a range of independent, reliable, published sources that discuss the subject. If you have a conflict of interest (e.g. you are the subject, an employee, or a relative) or are being paid to edit, you must disclose this to comply with Wikipedia's Terms of Use. Declined by WeirdNAnnoyed 4 months ago.

• Comment: Possibly notable, but the sourcing isn't good enough. Ref. 1 is fine, but Refs. 2-5 are primary and/or non-independent, and the rest aren't about the subject. Tone is also somewhat promotional. The formatting and malformed references are suggestive of AI use; this is not forbidden but requires extreme attention to detail with the referencing, to make sure that all sources are cited for statements they actually make. WeirdNAnnoyed (talk) 22:31, 30 March 2026 (UTC)

"Compact Sequencing" is a molecular diagnostic method based on a cylindrical microarray, the so-called “hybcell”.^[1][2]

The method combines Polymerase chain reaction (PCR) with array-based detection for the parallel analysis of multiple genetic targets. These may include pathogenic microorganisms, antimicrobial resistance markers, or genetic mutations relevant to infectious diseases and cancer.^[1][3][4]

The workflow typically involves amplification of target nucleic acids by PCR, during which the products are fluorescently labelled. The labelled amplicons are then applied to the hybcell, where complementary sequences hybridize to immobilized probes on the array surface. Hybridization is followed by enzymatic processing and washing steps to increase specificity, and fluorescence signals are detected and analysed computationally to determine the presence of specific targets.^[1][2]

The cylindrical design of the hybcell distinguishes it from conventional planar microarrays. This geometry facilitates controlled distribution of reagents and temperature and allows integration into automated processing systems. The technology has been applied in molecular diagnostics including the detection of pathogens and clinically relevant genetic markers, for example in infectious disease diagnostics such as sepsis and bloodstream infections.^[1][2][4]

The hybcell is the world's first cylindrical microarray. Dr. Bernhard Ronacher, the inventor of the compact sequencing technology, headed the molecular diagnostics laboratory of Lambda GmbH, which started out during the years 2000 to 2002. There he established the DNA array technology.

The underlying technology for compact sequencing has been described in patent applications, including a device for thermally regulating a rotationally symmetrical container (hybcell) used for nucleic acid detection.^[3] Ever since, the technology has found application in diverse fields including Oncology, Microbiology and Sepsis, with a global impact in hospitals and diagnostic laboratories.^[4][1][5] The technology has also been described in peer-reviewed publications.^[1][2][6]

The technology has been commercialised by Cube Dx, which develops diagnostic assays based on the hybcell platform. In 2023, the invention received the Houska Prize, winning first place in the Research & Development category in Austria.^[7][8]

Compact sequencing is a molecular diagnostic method that combines PCR amplification with array-based detection. Hybcells can be configured for DNA, protein, or small-molecule detection. Most applications require analysis on DNA or RNA-level, such as for example the detection of pathogens (e.g., bacterial, viral, or fungal pathogens) or drug-resistances. ^[9][1][2]

Extracted DNA or RNA is amplified using PCR or reverse-transcription PCR. Fluorescently labelled amplicons are then applied to the hybcell, containing immobilized probes corresponding to specific target sequences. Enzymatic extension of bound DNA and subsequent stringent washing allow distinction of sequences differing by a single nucleotide. The resulting fluorescence patterns are analysed computationally and reflect the presence of target sequences in the original sample.^[1][8][2]

The hybcell consists of a core, tube, lid, and handling tray. Up to 2,000 biomolecule spots, including DNA, proteins, or small molecules, are printed on the coated surface of the hybcell core. During analysis, the core rotates within the sample-containing tube to facilitate uniform contact with the hybridization solution, after which fluorescence detection provides data for downstream analysis.^[1][2]

The Hyborg device automates hybcell processing, including hybridization, washing, and fluorescence scanning. It processes multiple hybcells per run and generates digital output for analysis. Software associated with the device interprets fluorescence patterns to provide qualitative information on the presence of target sequences, including species identification or detection of specific point mutations.^[1][2][3]

Compact sequencing and the hybcell technology have found application in diverse fields, and are primarily focused on infectious disease diagnostics, such as pneumonia and bloodstream infections. Other applications include the detection of relevant point mutations in SARS CoV-2 spike protein or KRAS mutation testing in cancer diagnosis.^[1][8]

Beyond human diagnostics, compact sequencing has been adapted for example for wastewater monitoring and epidemiological surveillance.^[10]

Sepsis is one of the most common diseases and causes of death worldwide.^[11] Successful treatment and survival depend heavily on the early identification of causative pathogens.^[12] Traditional methods, including pathogen visualization by microscopy and culture-based techniques, typically require around 24 hours for results. Rapid molecular assays are increasingly used for timely identification of pathogens.^[12][6] Timely qualitative information about the pathogens present in the sample can aid treatment decisions including the administration or de-escalation of antibiotics, antimycotics and other measures.^[6][12]

The prelude method to the hybcell is the planar microarray, which is conventionally used in molecular diagnostics. However, processing times and hands-on time have hampered routine diagnostic use.^[13] By its cylindrical design and automated processing, the hybcell facilitates uniform reagent distribution resulting in shorter processing times and increased accuracy.^[1][14]

A study directly comparing the method with state-of-the-art next-generation sequencing methods such as pyrosequencing, Sanger sequencing, and 454 sequencing showed, that compact sequencing is suitable for applications requiring timely qualitative identification of clinically relevant point mutations, as it provides parallel detection of multiple targets within a panel.^[1] However, as a targeted method, compact sequencing is limited in that it does not provide exhaustive sequence information.^[1][6]

Specifically in the area of molecular diagnostics, rapid molecular assays are increasingly used to complement blood culture techniques in the diagnosis of infections.^[6] These molecular techniques are based on the detection of small biomolecules rather than viable organisms which infers a lower sensitivity - as there is no signal amplification by cell growth - but also a reduced bias towards fast-growing organisms.^[6] While rapid molecular assays, including compact sequencing, bear the benefit of timely indication, blood culture remains essential to identify phenotypic characteristics of microorganisms and giving definite information on the presence of viable pathogens.^[6][15]

Category:Genetics Category:Molecular biology Category:Medical diagnosis